Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 490.50
Ask: 495.50
Change: 0.00 (0.00%)
Spread: 5.00 (1.019%)
Open: 486.00
High: 493.00
Low: 484.50
Prev. Close: 490.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Treatt (TET): Sweet upgrades

19 May 2021 07:00

Edison Investment Research Limited Treatt (TET): Sweet upgrades 19-May-2021 / 07:00 GMT/BST


 

London, UK, 19 May 2021

 

Treatt (TET): Sweet upgrades

Treatt has once again demonstrated the strength of its business model, with another excellent set of results, and yet another upgrade to guidance. The performance continues to be testament to the management and culture of the business, which has been transformed under CEO Daemmon Reeve's nine years at the helm. Both sales and profit performance are impressive, and we once again raise our forecasts, as the 'healthier' categories continue to outperform. The relocation of the UK business is under way, and we expect the business to continue to perform well once the new UK capacity comes on stream.

 

Treatt trades at 40.7x and 28.1x FY21 P/E and EV/EBITDA, representing premiums of c 30% and c 40% respectively to its peers. We note that the current share price is discounting medium-term sales growth of 5.0%, falling to 2.5% in perpetuity, with a WACC of 5.7% and a terminal EBIT margin of 20.0%. We forecast net debt at end FY21, moving to a net cash position thereafter, and hence expect a significant uplift in the dividend in FY21.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Sara Welford +44 (0)20 3077 5700 consumer@edisongroup.com

Russell Pointon +44 (0)20 3077 5700 consumer@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1198024 19-May-2021 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
27th Nov 20187:00 amRNSFinal Results
16th Nov 201812:07 pmRNSSecond Price Monitoring Extn
16th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 201812:13 pmRNSHolding(s) in Company
13th Nov 20184:35 pmRNSPrice Monitoring Extension
9th Nov 20184:40 pmRNSSecond Price Monitoring Extn
9th Nov 20184:35 pmRNSPrice Monitoring Extension
6th Nov 20183:44 pmRNSHolding(s) in Company
16th Oct 20189:30 amRNSBoard Change
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
8th Oct 201812:07 pmRNSSecond Price Monitoring Extn
8th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20185:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSTrading Update
1st Oct 20184:51 pmRNSTotal Voting Rights
7th Sep 20184:35 pmRNSPrice Monitoring Extension
3rd Sep 20184:18 pmRNSDirector/PDMR Shareholding
3rd Sep 20188:58 amRNSHolding(s) in Company
23rd Aug 20184:19 pmRNSDirector/PDMR Shareholding
20th Aug 20181:41 pmRNSDirector/PDMR Shareholding
8th Aug 20184:00 pmRNSHolding(s) in Company
10th Jul 20184:52 pmRNSHolding(s) in Company
9th Jul 20183:32 pmRNSDirector/PDMR Shareholding
5th Jul 201812:11 pmRNSHolding(s) in Company
4th Jul 201812:08 pmRNSTotal Voting Rights
13th Jun 201810:14 amRNSDirector/PDMR Shareholding
11th Jun 20184:47 pmRNSHolding(s) in Company
8th Jun 20187:00 amRNSBlock Listing Application
5th Jun 201812:07 pmRNSBlock Listing Six Monthly Return - Replacement
4th Jun 20185:00 pmRNSHolding(s) in Company
4th Jun 201810:42 amRNSBlock Listing Six Monthly Return
1st Jun 201811:30 amRNSTotal Voting Rights
1st Jun 201811:24 amRNSHolding(s) in Company
31st May 20183:50 pmRNSCompletion of disposal
18th May 201811:13 amRNSDirector/PDMR Shareholding
11th May 20184:50 pmRNSDirector/PDMR Shareholding
8th May 20187:19 amRNSHalf-year Report
8th May 20187:15 amRNSDisposal
30th Apr 201812:20 pmRNSTotal Voting Rights and Capital
27th Apr 20184:39 pmRNSHolding(s) in Company
11th Apr 20183:56 pmRNSHolding(s) in Company
6th Apr 20181:31 pmRNSHolding(s) in Company
5th Apr 20187:00 amRNSTrading Update
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
5th Mar 20183:03 pmRNSDirector/PDMR Shareholding
8th Feb 20183:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.